FDA approves Kevzara for rheumatoid arthritis

After a resubmission by Sanofi and Regeneron Pharmaceuticals Inc., the FDA has approved Kevzara for the treatment of patients with rheumatoid arthritis, according to a company press release.

» Read more

Source: Healio